180 related articles for article (PubMed ID: 23650115)
1. Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome.
Lu S; Bevier M; Huhn S; Sainz J; Lascorz J; Pardini B; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Int J Cancer; 2013 Nov; 133(10):2325-33. PubMed ID: 23650115
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.
Lu S; Pardini B; Cheng B; Naccarati A; Huhn S; Vymetalkova V; Vodickova L; Buchler T; Hemminki K; Vodicka P; Försti A
PLoS One; 2014; 9(10):e111061. PubMed ID: 25350395
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.
Huhn S; Bevier M; Pardini B; Naccarati A; Vodickova L; Novotny J; Vodicka P; Hemminki K; Försti A
Cancer Causes Control; 2014 Jun; 25(6):759-69. PubMed ID: 24706189
[TBL] [Abstract][Full Text] [Related]
4. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
6. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
7. Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
Lu S; Catalano C; Huhn S; Pardini B; Partu L; Vymetalkova V; Vodickova L; Levy M; Buchler T; Hemminki K; Vodicka P; Försti A
PLoS One; 2019; 14(5):e0216666. PubMed ID: 31091244
[TBL] [Abstract][Full Text] [Related]
8. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
[TBL] [Abstract][Full Text] [Related]
9. Variations in mismatch repair genes and colorectal cancer risk and clinical outcome.
Vymetalkova V; Pardini B; Rosa F; Di Gaetano C; Novotny J; Levy M; Buchler T; Slyskova J; Vodickova L; Naccarati A; Vodicka P
Mutagenesis; 2014 Jul; 29(4):259-65. PubMed ID: 24755277
[TBL] [Abstract][Full Text] [Related]
10. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
12. Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk.
Sainz J; Rudolph A; Hoffmeister M; Frank B; Brenner H; Chang-Claude J; Hemminki K; Försti A
J Clin Endocrinol Metab; 2012 May; 97(5):E845-51. PubMed ID: 22419714
[TBL] [Abstract][Full Text] [Related]
13. Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer.
Ytting H; Christensen IJ; Steffensen R; Alsner J; Thiel S; Jensenius JC; Hansen U; Nielsen HJ
Scand J Immunol; 2011 Feb; 73(2):122-7. PubMed ID: 21198752
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
Mullany LE; Herrick JS; Wolff RK; Slattery ML
Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
[TBL] [Abstract][Full Text] [Related]
15. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic.
Pardini B; Kumar R; Naccarati A; Prasad RB; Forsti A; Polakova V; Vodickova L; Novotny J; Hemminki K; Vodicka P
Mutat Res; 2011 Mar; 721(1):74-80. PubMed ID: 21211571
[TBL] [Abstract][Full Text] [Related]
16. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
17. Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer.
Li L; Pan X; Li Z; Bai P; Jin H; Wang T; Song C; Zhang L; Gao L
Hum Immunol; 2013 Aug; 74(8):993-7. PubMed ID: 23628392
[TBL] [Abstract][Full Text] [Related]
18. GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.
Liu X; Jiang B; Wang A; Di J; Wang Z; Chen L; Su X
PLoS One; 2015; 10(8):e0136020. PubMed ID: 26287967
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Zhu X; Han Y; Yuan C; Tu W; Qiu G; Lu S; Lu H; Peng Z; Zhou C
Oncol Rep; 2015 Jan; 33(1):320-8. PubMed ID: 25338725
[TBL] [Abstract][Full Text] [Related]
20. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
